Lilly Q. Yue - Concepedia

Author

Lilly Q. Yue

United States Food and Drug Administration

Also Known As

L Yue, Lilly Q. Yue, Lilly Q. Yue*, Lilly Yue

Publications

3.4K

Citations

H-Index

Concepts

All Affiliations

United States Food and Drug Administration Center for Devices and Radiological Health Sidney Kimmel Comprehensive Cancer Center Johns Hopkins University National Center for Complementary and Integrative Health

About

Lilly Q. Yue is an author at United States Food and Drug Administration specializing in health policy, public health, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	16	2.7K
2	Public Health	13	17	2.6K
3	Engineering	3	3	2K
4	Health Sciences	2	2	178
5	Management	1	1	11

Lilly Q. Yue

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
Real-World Evidence — What Is It and What Can It Tell Us? Rachel E. Sherman, Steven A. Anderson, Gerald J. Dal Pan, New England Journal of Medicine Healthcare Monitoring SystemsEngineeringEhr SystemsReal-world EvidenceInformation Forensics	2016	1.9K
Comparison between surrogate indexes of insulin sensitivity/resistance and hyperinsulinemic euglycemic clamp estimates in rats Ranganath Muniyappa, Hui Chen, Radhika Muzumdar, American Journal of Physiology-Endocrinology and Metabolism	2009	180
QUICKI is a useful index of insulin sensitivity in subjects with hypertension Hui Chen, Gail W. Sullivan, Lilly Q. Yue, American Journal of Physiology-Endocrinology and Metabolism HypertensionBlood PressureObesityMetabolic SyndromeBody Composition	2003	161
Comparison between surrogate indexes of insulin sensitivity and resistance and hyperinsulinemic euglycemic clamp estimates in mice Sihoon Lee, Ranganath Muniyappa, Yan Xu, American Journal of Physiology-Endocrinology and Metabolism	2007	154
Propensity score-integrated power prior approach for incorporating real-world evidence in single-arm clinical studies Chenguang Wang, Heng Li, Wei-Chen Chen, Journal of Biopharmaceutical Statistics Bayesian StatisticReal-world EvidenceTreatment EffectBayesian InferenceSingle-arm Clinical Studies	2019	111
Statistical and Regulatory Issues with the Application of Propensity Score Analysis to Nonrandomized Medical Device Clinical Studies Lilly Q. Yue Journal of Biopharmaceutical Statistics Regulatory IssuesTreatment EffectPopulation Health SciencesPropensity Score MethodologyAdverse Event	2006	75
Statistical Considerations on Subgroup Analysis in Clinical Trials Mohamed Alosh, Kathleen Fritsch, Mohammad F. Huque, Statistics in Biopharmaceutical Research Biometric PrivacyGeneticsBiometricsGenetic EpidemiologyTemplate Protection	2015	70
Designing Premarket Observational Comparative Studies Using Existing Data as Controls: Challenges and Opportunities Lilly Q. Yue, Nelson Lu, Yunling Xu Journal of Biopharmaceutical Statistics Quasi-experimentPropensity Score MethodologyCausal InferencePreventive MedicineData Science	2014	58
Propensity score-integrated composite likelihood approach for augmenting the control arm of a randomized controlled trial by incorporating real-world data Wei-Chen Chen, Chenguang Wang, Heng Li, Journal of Biopharmaceutical Statistics Evidence-based InterventionReal-world DataTreatment EffectQuasi-experimentControl Arm	2020	54
A Note on Good Practice of Objective Propensity Score Design for Premarket Nonrandomized Medical Device Studies with an Example Heng Li, Vandana Mukhi, Nelson Lu, Statistics in Biopharmaceutical Research Patient SelectionTreatment EffectRiskbenefit RatioPropensity Score MethodologyAdverse Event	2016	37

Page 1